Combinations of calcitriol with anticancer treatments for breast cancer: an update

M Segovia-Mendoza, J García-Quiroz, L Díaz… - International journal of …, 2021 - mdpi.com
Preclinical, clinical, and epidemiological studies indicate that vitamin D3 (VD) deficiency is a
risk factor for the development of breast cancer. Underlying mechanisms include the ability …

Regular use of vitamin D supplement is associated with fewer melanoma cases compared to non-use: a cross-sectional study in 498 adult subjects at risk of skin …

E Kanasuo, H Siiskonen, S Haimakainen… - Melanoma …, 2023 - journals.lww.com
There are conflicting results on the role of vitamin D system in cutaneous carcinogenesis.
Therefore, it was investigated whether the use of oral vitamin D supplements associates with …

Vitamin D3 supplementation promotes regulatory T-cells to maintain immune homeostasis after surgery for early stages of colorectal cancer

P Srichomchey, S Sukprasert, N Khulasittijinda… - in vivo, 2023 - iv.iiarjournals.org
Abstract Background/Aim: Vitamin D3 (VD3) affects the regulation of the immune system,
including the differentiation and function of regulatory T-cells (Tregs). Tregs play an …

[HTML][HTML] Identifying a possible new target for diagnosis and treatment of postmenopausal osteoporosis through bioinformatics and clinical sample analysis

T Liu, J Huang, D Xu, Y Li - Annals of translational medicine, 2021 - ncbi.nlm.nih.gov
Background Postmenopausal osteoporosis, a common yet chronic systemic metabolic
disease, has become a major public health problem due to life expectancy increasing …

Cross-talk of aryl hydrocarbon receptor (AHR)-and vitamin D receptor (VDR)-signaling in Human keratinocytes

C Christofi, L Lamnis, A Stark, H Palm… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Vitamin D receptor (VDR), activated upon binding of 1, 25 (OH) 2D3, was
described as a tumor suppressor in the skin. New biological functions of non-classical …

Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy

A Fassio, G Porciello, G Carioli, E Palumbo, S Vitale… - Reumatismo, 2024 - iris.univr.it
Objective. To report cross-sectionally serum levels of 25-hydroxyvitamin D [25 (OH) D] in
women living in Italy within 12 months from breast cancer (BC) diagnosis. Methods. Baseline …

[HTML][HTML] Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies

A Tsuji, S Yoshikawa, S Morikawa, Y Ikeda… - … of Targeted Anti …, 2023 - ncbi.nlm.nih.gov
Immunotherapy strategies targeting immune checkpoint molecules such as programmed cell
death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) are …

Clinical impact of postoperative vitamin D deficiency on the recurrence of colon cancer after curative surgical resection

J Kim, DW Baek, JH Baek, BW Kang… - Anticancer …, 2021 - ar.iiarjournals.org
Background/Aim: There are no clinically significant cutoff values of serum vitamin D levels
and time points to predict the prognosis of colon cancer, particularly in patients who …

Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy

C Stephan, B Ralla, F Bonn, M Diesner, M Lein, K Jung - Cancers, 2022 - mdpi.com
Simple Summary Recent research on prostate cancer and vitamin D is controversial. We
measured three vitamin D3 metabolites in 32 selected prostate cancer patients after surgery …

维生素D3在移植免疫中的应用进展.

夏征, 周林 - Organ Transplantation/Qi Guan Yi Zhi, 2023 - search.ebscohost.com
维生素D3 是维持人体正常生理功能的重要维生素, 其代谢物及类似物具有强大的抗炎活性.
维生素D3 可在人体内活化转化为类固醇激素1α, 25-二羟维生素D3, 而1α, 25-二羟维生素D3 …